Efficacy and safety of eslicarbazepine acetate in acute manic episodes associated with bipolar I disorder: BIA-2093-203 phase II study results

Category Primary study
JournalJournal of the Neurological Sciences
Year 2013
This article has no abstract
Epistemonikos ID: 7ee6d8551c80a209894b609ce679bb6a66adc744
First added on: Jan 28, 2022